Flagship Ingrevia Private Limited

Flagship Ingrevia Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24290MH2021PTC359714 Incorporated 29 April 2021 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹90.43 Lakh
▲ 324% YoY
Net loss · FY 2025
₹86.08 Lakh
Net margin -95.2%
EBITDA · FY 2025
-₹67.55 Lakh
EBITDA margin -74.7%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Flagship Ingrevia Private Limited

Data last updated:

Flagship Ingrevia Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Flagship Biotech International Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 April 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC359714. Its GSTIN is 27AAECF5473D1ZO (Maharashtra).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Eswaran Krishnan Iyer and Shailesh Dilipbhai Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat 602 Floor 6 Marvela Patlipada Hiranandani Estate Internal Road, Thane, Maharashtra, India – 400607.

As per the financials filed for FY 2025, the company reported a revenue of ₹90.43 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹86.08 Lakh (net margin -95.2%) and EBITDA of -₹67.55 Lakh (EBITDA margin -74.7%).

Flagship Ingrevia Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0183314).

Company details

CIN U24290MH2021PTC359714
Registration Number 359714
Incorporation Date 29 April 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Flagship Biotech International Private Limited
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0183314

Recognitions & Rankings of Flagship Ingrevia

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-33-0183314

Contact details

Flagship Ingrevia Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat 602 Floor 6 Marvela Patlipada Hiranandani Estate Internal Road, Thane, Maharashtra, India – 400607
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Flagship Ingrevia Private Limited, buy the company report.

Comprehensive company report
Flagship Ingrevia Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Flagship Ingrevia is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Flagship Ingrevia Private Limited, buy the company report.

Financials of Flagship Ingrevia Private Limited

FY 2025 filings available

Flagship Ingrevia Private Limited reported revenue of ₹90.43 Lakh (up 324% YoY) for FY 2025.

Revenue · FY 2025
₹90.43 Lakh ▲ 324%
Net loss · FY 2025
₹86.08 Lakh margin -95.2%
EBITDA · FY 2025
-₹67.55 Lakh margin -74.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 324%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 49%

Revenue rose 324% in the latest year. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹67.55 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹86.08 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-74.7%
Net Profit Margin-95.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Flagship Ingrevia Private Limited, buy the company report.

Board of directors of Flagship Ingrevia Private Limited

Flagship Ingrevia has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Eswaran Krishnan IyerDirector29 Apr 20215 Years 6 MonthsCurrent
Shailesh Dilipbhai PatelDirector29 Apr 20215 Years 6 MonthsCurrent
Kedar Avinash VidhwansDirector29 Apr 20215 Years 6 MonthsCurrent

Peer comparison

Flagship Ingrevia Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aad Marketing Engineers Private Limited₹90.7 Lakh (FY 2025)-12.0%Nagpur, Maharashtra, India
MTC Graphics Private Limited₹90.65 Lakh (FY 2025)Chennai, Tamil Nadu, India
Shri Vaari Cements Private Limited₹90.6 Lakh (FY 2025)1016.0%Dharapuram, Tamil Nadu, India
GBM Steel Private Limited₹90.55 Lakh (FY 2024)-83.0%Indore, Madhya Pradesh, India
Aayyuskaam Private Limited₹90.54 Lakh (FY 2025)90.0%New Delhi, Delhi, India
Flagship Ingrevia Private Limitedthis company₹90.43 Lakh (FY 2025)-₹86.08 Lakh-95.2%324.0%Thane, Maharashtra, India
Fragrance Delivery Technologies Private Limited₹90.39 Lakh (FY 2024)48.0%Thane, Maharashtra, India
Cde Creative Connect Private Limited₹90.23 Lakh (FY 2025)1.0%Delhi, India
Ankal Tiles Private Limited₹90.21 Lakh (FY 2025)-2.0%Tirupur, Tamil Nadu, India
East India Coatings Private Limited₹90.21 Lakh (FY 2024)-48.0%Kolkata, West Bengal, India
Sathi Agricultural Multi Himghar Private Limited₹90.21 Lakh (FY 2025)33.0%Purbo Bardhaman, West Bengal, India

To see the full peer comparison of Flagship Ingrevia Private Limited, buy the company report.

Auditor

Flagship Ingrevia Private Limited is audited by DINESH AMOD KELKAR for the financial year 2023.

Auditor firmFinancial yearFirm registration number
DINESH AMOD KELKARFY 2023046900

Shareholding

The shareholding of Flagship Ingrevia Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Flagship Ingrevia Private Limited, buy the company report.

MSME payment delays

Flagship Ingrevia Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 30 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
Flagship Biotech International Private Limited
CS Continental Marketing Private Limited

To see the full MSME payment records of Flagship Ingrevia Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Flagship Ingrevia Private Limited has 1 active EPFO establishment as of Apr 04, 2024.

Active EPFO establishments
1

GST

Flagship Ingrevia has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECF5473D1ZOMaharashtraActive05 Jun 2021

To see the full GST registrations and return filing status of Flagship Ingrevia Private Limited, buy the company report.

Recent activity

Flagship Ingrevia Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Mukeshkumar Nathalal Vaghela ceased to be Director on 31 Mar 2023.

AGM
Flagship Ingrevia Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Flagship Ingrevia Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Mukeshkumar Nathalal Vaghela ceased to be Director.
Appointed
Eswaran Krishnan Iyer was appointed as Director.
Appointed
Kedar Avinash Vidhwans was appointed as Director.
Appointed
Shailesh Dilipbhai Patel was appointed as Director.
Incorporation
29 Apr 2021
Flagship Ingrevia Private Limited was registered on 29 Apr 2021 with Roc Mumbai & aged 5 years 6 months as per MCA records.

Frequently asked questions

Flagship Ingrevia is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 April 2021 (5+ years old) and is registered under CIN U24290MH2021PTC359714.

Flagship Ingrevia has 3 current directors:

The latest financial statements of Flagship Ingrevia on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Flagship Ingrevia is 27AAECF5473D1ZO, registered in Maharashtra.

The CIN (Corporate Identification Number) of Flagship Ingrevia is U24290MH2021PTC359714. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Flagship Ingrevia was incorporated on 29 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Flagship Ingrevia by revenue are Aad Marketing Engineers Private Limited, MTC Graphics Private Limited, Shri Vaari Cements Private Limited, GBM Steel Private Limited, Aayyuskaam Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).

Mukeshkumar Nathalal Vaghela ceased to be Director on 31 Mar 2023. Eswaran Krishnan Iyer was appointed as Director on 29 Apr 2021. Kedar Avinash Vidhwans was appointed as Director on 29 Apr 2021. Flagship Ingrevia has 4 board changes on record in total.

Yes, Flagship Ingrevia is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0183314).

Flagship Ingrevia has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 30 overdue payments to 2 micro and small suppliers. The latest return was filed on 29 Aug 2023.

The registered office of Flagship Ingrevia is at Flat 602 Floor 6 Marvela Patlipada Hiranandani Estate Internal Road, Thane, Maharashtra, India – 400607.

Flagship Ingrevia operates in the pharma industry, in the drug formulation and development segment.